BioSpace News Archive

Cerevel Therapeutics, a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, reported financial results for the third quarter ended September 30, 2023 and provided key pipeline and business updates.

IDEXX Laboratories, Inc., a global leader in pet healthcare innovation, announced third quarter results.

Merck, known as MSD outside of the United States and Canada, announced that the Phase 3 KEYNOTE-564 trial evaluating KEYTRUDA, Merck’s anti-PD-1 therapy, met its key secondary endpoint of overall survival, for the adjuvant treatment of patients with renal cell carcinoma at intermediate-high or high risk of recurrence following nephrectomy, or following nephrectomy and resection of metastatic lesions.

Karuna Therapeutics, Inc. announced it will be presenting new efficacy, safety, and tolerability analyses from its EMERGENT program evaluating KarXT in adults with schizophrenia at the upcoming Neuroscience Education Institute Congress, to be held November 9-12, 2023, in Colorado Springs, CO.

ADMA Biologics, Inc. announced that it will report third quarter 2023 financial results on November 8, 2023, after the U.S. financial markets close.

Amicus Therapeutics announced that management will participate in upcoming presentations at the following investor conferences in November.

Monopar Therapeutics Inc. will present data from its ongoing Phase 1b open-label, dose-escalating clinical trial of camsirubicin in patients with advanced soft tissue sarcoma later at the 2023 Connective Tissue Oncology Society Annual Meeting, which is bringing together the world’s leading sarcoma specialists.

Invitae (NYSE: NVTA), a leading medical genetics company, today announced that it will report its third quarter 2023 financial results on Wednesday, November 8, 2023 , and will host a conference call and webcast that day at 4:30 p.m. Eastern / 1:30 p.m. Pacific to discuss its financial results and recent highlights.

Embolx Inc, a leading provider of minimally invasive medical devices, is delighted to announce its international distribution partnership with Girlow USA, a renowned global distributor of advanced medical equipment.

Tract Bio today announced the publication of a research article in the American Journal of Respiratory and Critical Care Medicine (AJRCCM) highlighting the stem cell variants driving chronic lung inflammation in modulator-treated cystic fibrosis patients (CFTR modulators).